Abstract:BACKGROUND:Type I insulin-like growth factor receptor (IGF-IR) tyrosine kinase induces significant oncogenic effects. Strategies to block IGF-IR signaling are being tested in clinical trials that include patients with aggressive solid malignancies. Mantle cell lymphoma is a B-cell neoplasm with poor prognosis and a tendency to develop resistance. The expression and potential significance of IGF-IR in mantle cell lymphoma are not known.DESIGN AND METHODS:We used reverse transcriptase polymerase chain reaction, quantitative real-time polymerase chain reaction, immunoprecipitation, western blotting, flow cytometry, and immunohistochemistry to analyze the expression of IGF-IR mRNA, and IGF-IR and pIGF-IR proteins in mantle cell lymphoma cell lines and patients' specimens. Selective and specific blockade of IGF-IR was achieved using picropodophyllin and short-interfering RNA, respectively. Cell viability, apoptosis, cell cycle, cellular morphology, cell proliferation, and target proteins were then analyzed.RESULTS:We detected the expression of IGF-IR and pIGF-IR in mantle cell lymphoma cell lines. Notably, IGF-IR molecules/cell were markedly increased in mantle cell lymphoma cell lines compared with human B-lymphocytes. IGF-IR and pIGF-IR were also detected in 78% and 74%, respectively, of 23 primary mantle cell lymphoma specimens. Treatment of serum-deprived mantle cell lymphoma cell lines with IGF-I salvaged these cells from apoptosis. Selective inhibition of IGF-IR by picropodophyllin decreased the viability and proliferation of mantle cell lymphoma cell lines, and induced apoptosis and cell cycle arrest. Selective inhibition of IGF-IR was associated with caspase-3, caspase-8, caspase-9, and PARP cleavage, cytochrome c release, up-regulation of cyclin B1, and down-regulation of cyclin D1, pCdc2, pIRS-1, pAkt, and pJnk. Similar results were obtained by using IGF-IR short-interfering RNA. In addition, picropodophyllin decreased the viability and proliferation of primary mantle cell lymphoma cells that expressed IGF-IR.CONCLUSIONS:IGF-IR is up-regulated and frequently activated in mantle cell lymphoma. Our data suggest that IGF-IR could be a molecular target for the treatment of mantle cell lymphoma.

Over-Expression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes.

[Expression of Insulin-like Growth Factor Recepter Type I in CD34+ Cells of Patients with Myelodysplastic Syndromes].

Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis

Expression of insulin-like growth factor-1 receptor and its significance in myelodysplastic syndromes

Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome Via IGF-IR

[Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations].

Expression and Clinical Significance of ID1 Gene in Acute Myeloid Leukemia

IGF‑IR Promotes Clonal Cell Proliferation in Myelodysplastic Syndromes Via Inhibition of the MAPK Pathway.

Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes.

High IDH1 Expression is Associated with a Poor Prognosis in Cytogenetically Normal Acute Myeloid Leukemia.

IGF-IR Determines the Fates of BCR/ABL Leukemia

High Frequency of Clonal Immunoglobulin Receptor Gene Rearrangements in Sporadic Histiocytic/Dendritic Cell Sarcomas

Differentiation and Hematopoietic-Support of Clonal Cells in Myelodysplastic Syndromes.

Clonality Investigation of Morphologically Dysplastic Hematopoietic Cells in Myelodysplastic Syndrome Marrows

Expression and Significance of CD117 in Bone Marrow of Patients with Myelodysplastic Syndrome

Expression and significance of CD34, CD117 on bone marrow mononuclear cells of patients with myelodysplastic syndrome

Minimal Residual Disease Detection by Next-Generation Sequencing of Different Immunoglobulin Gene Rearrangements in Pediatric B-ALL

Expressions of cell cycle related molecules in myelodysplastic syndrome

Expression and Effects of Inhibition of Type I Insulin-Like Growth Factor Receptor Tyrosine Kinase in Mantle Cell Lymphoma.

Genetic and Immunophenotypic Profile of IGH@ Rearrangement Detected by Fluorescence in Situ Hybridization in 149 Cases of B-cell Chronic Lymphocytic Leukemia